Biopure Corporation   Report issue

For profit Phase 2
Founded: Cambridge MA United States (1984)
Status: Defunct (2014)

Organization Overview

First Clinical Trial
2003
NCT00317512
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 2)

Angina Pectoris (Phase 2)

Angina, Unstable (Phase 2)

Coronary Artery Disease (Phase 2)

Coronary Occlusion (Phase 2)

Infarction (Phase 2)

Ischemia (Phase 2)

Myocardial Infarction (Phase 2)

Peripheral Arterial Disease (Phase 2)

Peripheral Vascular Diseases (Phase 2)

Vascular Diseases (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 3